We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
1576
People Inc
PPLI
$2.78B
| $154K | ﹤0.01% |
2,990
-482
| -14% | -$22.1K |
|
1577
Baker Hughes
BKR
$55.9B
| $150K | ﹤0.01% |
4,754
-933
| -16% | -$27.2K |
|
1578
Rollins
ROL
$16.1B
| $150K | ﹤0.01% |
3,494
+1,794
| +106% | +$72.9K |
|
1579
Willdan Group
WLDN
$1.19B
| $148K | ﹤0.01% |
7,750
-465
| -6% | -$7.82K |
|
1580
CDW
CDW
$18.7B
| $148K | ﹤0.01% |
805
+1
| +0.1% | +$175 |
|
1581
Marriott International
MAR
$87.3B
| $147K | ﹤0.01% |
799
-81
| -9% | -$14.1K |
|
1582
Essex Property Trust
ESS
$17.4B
| $147K | ﹤0.01% |
626
-1,444
| -70% | -$316K |
|
1583
Vitamin Cottage Natural Grocers
NGVC
$672M
| $146K | ﹤0.01% |
+11,887
| New | +$134K |
|
1584
eHealth
EHTH
$27.5M
| $141K | ﹤0.01% |
17,582
+3,847
| +28% | +$30.8K |
|
1585
Outfront Media
OUT
$4.96B
| $138K | ﹤0.01% |
8,890
-32,769
| -79% | -$493K |
|
1586
Enphase Energy
ENPH
$4.7B
| $136K | ﹤0.01% |
815
-3,817
| -82% | -$682K |
|
|
MCHB
1587
Mechanics Bancorp
MCHB
$3.39B
| $134K | ﹤0.01% |
22,589
-27,337
| -55% | -$257K |
|
1588
Mercantile Bank Corp
MBWM
$1.05B
| $132K | ﹤0.01% |
4,772
-161
| -3% | -$4.46K |
|
|
VMRK
1589
Vivmark Residential
VMRK
$48.7B
| $132K | ﹤0.01% |
1,996
-1,769
| -47% | -$111K |
|
1590
Eversource Energy
ES
$25.6B
| $127K | ﹤0.01% |
1,796
-80
| -4% | -$5.96K |
|
1591
AMERISAFE
AMSF
$458M
| $124K | ﹤0.01% |
+2,332
| New | +$124K |
|
1592
International Flavors & Fragrances
IFF
$21.5B
| $124K | ﹤0.01% |
1,560
+355
| +29% | +$30.5K |
|
1593
Carnival Corporation Ltd
CCL
$30.6B
| $120K | ﹤0.01% |
+6,383
| New | +$74.7K |
|
1594
Edison International
EIX
$21.1B
| $118K | ﹤0.01% |
1,704
-343
| -17% | -$24.1K |
|
|
JAMF
1595
DELISTED
Jamf
JAMF
| $118K | ﹤0.01% |
+6,052
| New | +$112K |
|
1596
Xeris Biopharma Holdings
XERS
$1.42B
| $117K | ﹤0.01% |
+44,839
| New | +$114K |
|
|
JNPR
1597
DELISTED
Juniper Networks
JNPR
| $114K | ﹤0.01% |
3,649
+780
| +27% | +$24K |
|
1598
Carrier Global
CARR
$44.7B
| $113K | ﹤0.01% |
2,265
-14,633
| -87% | -$644K |
|
|
BBT
1599
Beacon Financial Corp
BBT
$2.61B
| $111K | ﹤0.01% |
5,360
-14
| -0.3% | -$302 |
|
1600
Mid-America Apartment Communities
MAA
$14.1B
| $111K | ﹤0.01% |
728
-25
| -3% | -$3.76K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.